An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the pilot stage as an effort to incentivize pharma manufacturers to achieve a more mature state of quality culture.
Somnath Mishra
Advertisement
President, Shabas Solutions LLC
Articles by Somnath Mishra
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Imposes 100% Tariffs on Branded Pharmaceuticals
2
The New Antitrust Era: Why CVS-Style Healthcare Integration is Now the FTC’s Primary Target
3
Shionogi Enters $2.5 Billion Agreement to Acquire All Rights to Radicava
4
Trump Administration’s Leadership Carousel Across Key Agencies
5